Alpha Amylase Baking Enzyme Market

Novonesis lifted its 2026 organic sales outlook to 7-8% on 19 August 2026, after its first-half report showed Food and Health biosolutions growing 9% organically, driven by Food and Beverages, the business that sells Novamyl and BAN amylases to bakers. The Alpha Amylase Baking Enzyme Market covers starch-degrading alpha-amylases dosed into flour and dough: fungal alpha-amylase for gassing and crust colour, maltogenic alpha-amylase for anti-staling, and bacterial and thermostable grades for specialty breads. Douglas Insights sizes it at USD 371.5 million in 2025, the product of 14,320 tonnes of formulated enzyme and an average realised price of USD 25.94 per kilogram, and projects USD 595.1 million by 2035, a revenue CAGR of 4.82%. The study belongs to our Functional Ingredients research, and each input is documented under the Douglas Insights research methodology.

Which enzyme companies supply alpha amylase to industrial bakeries, and how concentrated is the field?

Six enzyme companies supply most alpha amylase to bakers, and Douglas Insights estimates the top three hold 63.8% of 2025 alpha amylase baking enzyme revenue, or USD 237.0 million. Novonesis leads with about 31.6% because Novamyl defined maltogenic anti-staling bread enzymes.

Novonesis built its baking enzyme position on maltogenic alpha-amylase. Its Novamyl Boost page calls the granulate “our newest premium freshness product” and explains that it modifies amylopectin to slow starch recrystallisation, the main cause of bread staling. Douglas Insights puts Novonesis near USD 117.4 million of 2025 alpha amylase baking enzyme sales. Group figures give the scale: in its full-year 2025 highlights of 25 February 2026, Novonesis reported sales of EUR 4.16 billion, 7% organic growth, Food and Health biosolutions of EUR 1.87 billion and Food and Beverages of EUR 1.37 billion growing 8% organically. Food and Beverages is therefore 33.0% of group sales.

IFF ranks second. It sells POWERFresh and POWERSoft amylases under the Danisco brand, and on 17 March 2021 it launched a new range of anti-staling amylases for sweet baked goods in China, citing higher sugar tolerance than standard softening enzymes. dsm-firmenich is third: its BakeZyme range includes BakeZyme Master, a maltogenic amylase that keeps bread soft and moist even after 7 days, and BakeZyme AAA, a blend that cuts ascorbic acid dosage.

AB Enzymes, part of ABF Ingredients, sells VERON M4, a concentrated fungal alpha-amylase that regulates gassing and speeds fermentation. Kerry targets sweet goods with Biobake Fresh Rich. Amano Enzyme, a specialty enzyme maker, describes alpha-amylase as an alternative to synthetic dough additives. Improver houses and flour mills buy from all six and blend the enzymes into bread improvers.

Which alpha amylase type leads baking enzyme revenue: maltogenic, fungal or bacterial?

Maltogenic alpha-amylase leads alpha amylase baking enzyme revenue with 44.6% of 2025 value, or USD 165.7 million, because anti-staling sells at about USD 49.91 per kilogram. Fungal alpha-amylase carries more tonnage but only 41.7% of value.

Maltogenic alpha-amylase is worth USD 165.7 million in 2025 and reaches USD 298.7 million by 2035, the fastest rate at 6.07% a year. Bakers dose it to slow retrogradation, so packaged sandwich bread and buns stay soft through a week of shelf life, and each extra day cuts returns from retailers. Douglas Insights counts 3,320 tonnes of maltogenic product in 2025.

Fungal alpha-amylase holds 41.7%, or USD 154.9 million, and grows 3.62% a year to USD 221.1 million. Mills add it to correct low falling numbers in flour, and bakers use it to feed yeast and colour the crust; at about USD 20.54 per kilogram across 7,540 tonnes it is the volume workhorse.

Bacterial and thermostable alpha-amylase adds 13.7%, or USD 50.9 million, growing 3.88% a year to USD 74.5 million. Heat-stable grades survive longer into the bake, which suits rye breads, tortillas and flatbreads, but overdosing leaves a gummy crumb, so usage stays specialist at roughly USD 14.71 per kilogram.

Which bakery products and enzyme formats use alpha amylase, from sandwich bread to tortillas?

Pan bread and rolls absorb about 58.2% of alpha amylase baking enzyme value, Douglas Insights estimates, because industrial loaves need both fermentation and anti-staling enzymes. Cakes and sweet goods take 24.9%, tortillas and flatbreads 16.9%.

By form, powder blends dominate, because improver houses and flour mills mix enzymes into dry improvers; granulate is growing for dust-free handling, as the Novamyl Boost granulate shows; liquid dosing serves the largest plant bakeries with automated lines. By end user, industrial bakeries buy about 46.3% of alpha amylase value directly or through improvers, improver houses and flour mills 39.5%, and craft bakeries 14.2%, by our estimates. Sweet goods are the growth pocket: the IFF and Kerry launches both target cakes, muffins and buns with high sugar recipes that defeat ordinary softening enzymes.

Why are industrial bread lines adding more maltogenic alpha amylase each year?

Alpha amylase baking enzyme tonnage grows 3.42% a year, and three drivers explain all of it: shelf-life extension adds 1.46 points, clean-label additive replacement 0.97 points and sweet goods in Asia 0.99 points. Price adds 1.36% a year.

Shelf-life extension contributes 1.46 points. Plant bakeries deliver packaged bread to retailers on two or three runs a week, so every day of softness beyond day five reduces unsold returns. dsm-firmenich states that BakeZyme Master keeps bread soft and moist even after 7 days, and Novonesis positions Novamyl Boost on extra softness throughout shelf life. Industrial loaves are the bulk of that volume: a plant bakery running 24 hours on three lines can ship hundreds of tonnes of bread a week, and an anti-staling enzyme that adds two days of softness lets it cut delivery runs from three to two. Douglas Insights calculates that the maltogenic segment alone grows from 165.7 to 298.7 USD million between 2025 and 2035, about 59.5% of all new alpha amylase baking enzyme value.

Clean-label additive replacement contributes 0.97 points. Bakers are taking chemical emulsifiers and oxidisers out of ingredient lists, and enzymes used as processing aids usually do not need a label declaration in the finished bread. BakeZyme AAA is sold to cut ascorbic acid dosage, and AB Enzymes markets VERON enzymes inside bread improvers built for shorter labels. Bread improvers sold to supermarket in-store bakeries follow the same path, and an improver house that reformulates one line typically replaces 2 or 3 chemical ingredients with an enzyme blend. Each improver reformulation adds fungal and maltogenic alpha-amylase tonnage at USD 20.54 to USD 49.91 per kilogram.

Sweet goods in Asia contribute 0.99 points. IFF opened its China range on 17 March 2021 because Chinese consumers expect cakes and buns to stay soft, and sugar-rich doughs need amylases that tolerate high sugar levels. Douglas Insights projects Asia Pacific alpha amylase baking enzyme value rising 6.64% a year, from USD 90.3 million to USD 171.7 million. The corporate tailwind is visible too: Novonesis reported Food and Health growth of 9% in the first half of 2026, led by Food and Beverages.

Add the three: 1.46 plus 0.97 plus 0.99 equals the 3.42-point volume leg, lifting shipments from 14,320 tonnes in 2025 to about 20,044 tonnes in 2035. A richer mix toward maltogenic grades then lifts the average price from USD 25.94 to USD 29.69 per kilogram.

Which flour, cost and approval bottlenecks slow alpha amylase baking enzyme growth?

Alpha amylase baking enzyme value loses about 0.93 points a year to three brakes: malted flour and flour variability, price pressure on fungal grades, and approval costs. Without them, value would grow near 5.76% instead of 4.82%.

Malted flour and flour variability remove 0.38 points. Many mills still correct falling numbers with malted barley or wheat flour, a cheaper source of cereal alpha-amylase, and sprouted harvests with high natural enzyme activity cut the dose bakers need. In a wet harvest year, fungal alpha-amylase demand from mills can drop by 10% to 15%, Douglas Insights estimates.

Price pressure removes 0.31 points. Fungal alpha-amylase is produced by several suppliers in Europe, China and India, and improver houses tender it by the tonne, so realised prices near USD 20.54 per kilogram rise more slowly than the 1.36% average. Fermentation scale lets the leaders defend margin while smaller producers compete on price.

Approval costs remove 0.24 points. Every new alpha amylase strain needs a safety dossier before it can be sold, and in the EU food enzymes are assessed under the regulation adopted on 16 December 2008, which created the framework for a Union list. Each dossier costs months of toxicology and production-strain work, so new anti-staling grades reach bakers more slowly.

Where do bakeries buy the most alpha amylase: Europe, North America or Asia Pacific?

Europe buys the most alpha amylase baking enzyme, USD 125.6 million or 33.8% of 2025 value, because plant bread, improver houses and enzyme producers cluster there. Asia Pacific grows fastest at 6.64% a year on sweet buns and cakes.

Europe grows 3.97% a year to USD 185.4 million by 2035; mature bread volumes slow it, but Germany, France and the Netherlands keep buying premium freshness grades. North America holds USD 109.2 million in 2025 and reaches USD 166.5 million at 4.31%, carried by long-life sandwich bread and buns sold through supermarkets.

Asia Pacific starts at USD 90.3 million and is the fastest region at 6.64% a year, because packaged bread and sweet buns are replacing fresh rice and noodle snacks in Chinese, Indonesian and Indian cities. Latin America adds USD 29.3 million at 5.12%, with Mexican tortillas and Brazilian pan bread the main uses of alpha amylase. Middle East and Africa is the wildcard at USD 17.1 million, growing 3.10% a year: flatbread volumes are vast, but most bakeries are small and unpackaged, so enzyme doses per tonne of flour stay low.

Readers following enzyme supply more broadly can compare our Industrial Enzymes Market study, and the microbial fermentation business that shares production know-how with enzyme makers in the Probiotic Culture Market report.

How much do bakeries pay per kilogram of fungal and maltogenic alpha amylase?

Douglas Insights reckons bakers paid USD 25.94 per kilogram of alpha amylase baking enzyme in 2025 on average. Bacterial grades sit near USD 14.71 and maltogenic anti-staling grades near USD 49.91, reflecting activity and dose.

Realised price bands run wider than the averages. Fungal alpha-amylase sells at roughly USD 14 to USD 27 per kilogram depending on activity and formulation; maltogenic alpha-amylase at USD 38 to USD 65; bacterial and thermostable grades at USD 10 to USD 19. Granulates carry a premium of 8% to 12% over powders for low dust. Dose matters more than list price: maltogenic enzymes are added at tens of parts per million of flour, so the cost per loaf stays a fraction of a cent.

The average rises 1.36% a year to USD 29.69 by 2035, mostly from mix shift toward maltogenic grades rather than list price increases. Supplier margins support that: Novonesis guided its adjusted EBITDA margin to the higher end of 37-38% for 2026.

Which EU food enzyme rules must alpha amylase suppliers comply with?

Alpha amylase baking enzymes sold in the EU fall under Regulation (EC) No 1332/2008 on food enzymes, adopted on 16 December 2008 and published on 31 December 2008. The regulation set up a single authorisation route and a Union list for food enzymes.

For alpha amylase suppliers, that means each production strain, from Aspergillus fungal amylase to Bacillus maltogenic amylase, needs a safety evaluation before inclusion on the Union list. Enzymes used as processing aids in bread are treated differently from additives on the label, which supports clean-label reformulation. Bakers also check halal, kosher and non-GMO status, so suppliers keep separate certificates for each alpha amylase grade.

What if anti-staling alpha amylase adoption runs faster or slower to 2035?

The base path gives the alpha amylase baking enzyme sector USD 595.1 million in 2035. A slower path reaches USD 513.5 million and a faster path USD 689.1 million. Volume growth from 2.45% to 4.38% explains most of the gap.

The slower case pairs 2.45% volume with 0.82% price, a 3.29% CAGR, if mills return to malted flour and fungal prices slide. The faster case pairs 4.38% volume with 1.91% price, a 6.37% CAGR, if Asian sweet goods adopt maltogenic grades as quickly as North American bread did. One extra point of tonnage growth lifts the 2035 alpha amylase value by about USD 60.2 million; one point less removes USD 55.1 million.

Published baking enzyme and amylase forecasts sit between 4.3% and 6.8% a year, and our 4.82% base is in the lower half because it counts only alpha-amylase and prices fungal tonnage at commodity levels. The Novonesis upgrade of 19 August 2026 is a base-case assumption: if Food and Beverages keeps growing 8% to 9%, the faster path gains weight.

Douglas Exclusive: the Alpha Amylase Baking Enzyme Freshness Calendar

The Freshness Calendar is a Douglas Insights model, not an official schedule, built from 13 inputs. Six are dated events read on company and EU pages; seven are model values (2025 size, two growth legs, three segment rates and the Asia Pacific rate). It places each event and each modelled milestone on one timeline.

The finding: the alpha amylase calendar is front-loaded with regulation and back-loaded with Asian demand. Regulatory dates set the cost of entry, while the decisive commercial date is 2034, when Asia Pacific alpha amylase baking enzyme value passes North America. Suppliers without sugar-tolerant maltogenic grades by then miss the fastest pocket.

How we built the alpha amylase baking enzyme receipt: what do 14,320 tonnes earn?

The receipt multiplies 14,320 tonnes of formulated alpha amylase by USD 25.94 per kilogram to give USD 371.5 million for 2025. Tonnage splits into 3,320 tonnes maltogenic, 7,540 tonnes fungal and 3,460 tonnes bacterial and thermostable.

Forward, 14,320 tonnes growing 3.42% a year reach about 20,044 tonnes in 2035, and USD 25.94 growing 1.36% reaches USD 29.69; the product is USD 595.1 million. The model covers 5 regions, 3 enzyme types, 6 companies, 1 EU regulation and 4 published growth rates.

Cross-checks: the three type rows sum to USD 594.3 million in 2035, within 0.13% of the total, and the five regions reconcile to the global row. A published 2024 alpha-amylase baking estimate of USD 333 million grown at our 4.82% gives USD 349.1 million for 2025, 6.4% below our figure.

What should bakers, improver houses and alpha amylase suppliers do before 2030?

Alpha amylase buyers should plan on 4.82% annual value growth, with money moving to maltogenic grades at 6.07% a year. Lock in anti-staling supply early.

Plant bakeries should test maltogenic doses for an extra day of shelf life before 2027. Improver houses should qualify two fungal alpha-amylase sources. Suppliers should build sugar-tolerant grades for Asia Pacific, where value nearly doubles from USD 90.3 million to USD 171.7 million. Investors should watch Novonesis Food and Beverages growth as the bellwether. Readers tracking texture claims can also see our Mouthfeel Enhancing Ingredient Market study.

Sources

1. Novonesis H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook (2026)
2. Novonesis Novonesis 2025 full-year highlights (2026)
3. Novonesis Novamyl Boost maltogenic amylase (2026)
4. IFF IFF launches new range of anti-staling amylases for sweet baked goods in China (2021)
5. dsm-firmenich BakeZyme (2026)
6. EUR-Lex Regulation (EC) No 1332/2008 on food enzymes (2008)